-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ORcURUpnOI1ckW/Bz+2MFf8YIgemOz3LufqrbjyMLEoWxBIFC6E3l5tNsfCp/fU8 /7MzDJGPo/rRkl8g+63RCg== 0001231977-05-000028.txt : 20050831 0001231977-05-000028.hdr.sgml : 20050831 20050831160125 ACCESSION NUMBER: 0001231977-05-000028 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050731 FILED AS OF DATE: 20050831 DATE AS OF CHANGE: 20050831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOTOLA NANCY CENTRAL INDEX KEY: 0001231955 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 051061929 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 5 1 primary_doc.xml PRIMARY DOCUMENT X0202 5 2005-07-31 0 0 1 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231955 MOTOLA NANCY C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 0 1 0 0 SVP, Regulatory & QA Common Stock, par value $.0001 2001-10-07 4 J 0 L 85 0 A 3000 I by Spouse The reporting person may be deemed to have acquired beneficial ownership of these shares upon her marriage to the owner on 10/7/2001. The reporting person disclaims beneficial ownership of these shares. This amount excludes the 85 shares reported under this Form because the reporting person disclaims beneficial ownership thereof. /s/ Nancy Motola 2005-08-31 -----END PRIVACY-ENHANCED MESSAGE-----